BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19634138)

  • 1. Role of microRNA in anticancer drug resistance.
    Zheng T; Wang J; Chen X; Liu L
    Int J Cancer; 2010 Jan; 126(1):2-10. PubMed ID: 19634138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of long non-coding RNA in tumor drug resistance.
    Deng H; Zhang J; Shi J; Guo Z; He C; Ding L; Tang JH; Hou Y
    Tumour Biol; 2016 Sep; 37(9):11623-11631. PubMed ID: 27380056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA and drug resistance.
    Ma J; Dong C; Ji C
    Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and cancer resistance: A new molecular plot.
    Fanini F; Fabbri M
    Clin Pharmacol Ther; 2016 May; 99(5):485-93. PubMed ID: 26875151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21: a novel therapeutic target in human cancer.
    Pan X; Wang ZX; Wang R
    Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as new therapeutic targets and tools in cancer.
    Gandellini P; Profumo V; Folini M; Zaffaroni N
    Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-130a in cancer.
    Zhang HD; Jiang LH; Sun DW; Li J; Ji ZL
    Breast Cancer; 2017 Jul; 24(4):521-527. PubMed ID: 28477068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of breast cancer resistance to anthracyclines or taxanes: an overview of the proposed roles of noncoding RNA.
    Li XJ; Zha QB; Ren ZJ; Tang JH; Yao YF
    Curr Opin Oncol; 2015 Nov; 27(6):457-65. PubMed ID: 26371779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
    Kanakkanthara A; Miller JH
    Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
    Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
    Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of micro-RNAs in drug resistance of multiple myeloma.
    Abdi J; Jian H; Chang H
    Oncotarget; 2016 Sep; 7(37):60723-60735. PubMed ID: 27494872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells.
    Xu K; Liang X; Cui D; Wu Y; Shi W; Liu J
    Mol Carcinog; 2013 Jan; 52(1):70-8. PubMed ID: 22121083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.